Holocene Advisors, LP Biohaven Pharmaceutical Holding CO Ltd. Call Options Transaction History

Holocene Advisors, LP

  • $22.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021
BUY
$65.78 - $105.02 $16.1 Million - $25.7 Million
245,000 New
245,000 $23.8 Million
Q1 2021

May 17, 2021
SELL
$64.07 - $91.75 $19.2 Million - $27.5 Million
-300,000 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$65.07 - $98.24 $27.2 Million - $41 Million
-417,500 Reduced 58.19%
300,000 $25.7 Million
Q1 2020

May 15, 2020
BUY
$27.51 - $57.29 $19.7 Million - $41.1 Million
717,500 New
717,500 $24.4 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Holocene Advisors, LP Portfolio

Follow Holocene Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Holocene Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email